In contrast, low SETDB1 expression in melanoma (SKCM) and non‐small cell lung cancer (NSCLC) patients was associated with better radiotherapy outcomes, greater immune cell infiltration, and enhanced IFN response following SETDB1 depletion.39 Here, SETDB1 is linked to melanoma.